Q32 Bio
NASDAQ: QTTBFounded 2017 · 30 employees on LinkedIn · 6 known investors
Find your way into Q32 Bio
332 people in our graph share verified history with the Q32 Bio team — schools, employers, funds. One of them is your warm intro.
Issi Rozenunlockedknows Jodie Morrison · together at Verve Therapeutics (overlapped)
×2knows the team · via Yale University
×3knows the team · via MIT Sloan School of Management
×2knows the team · via Atlas Venture
×2knows the team · via Yale University School of Medicine
×2knows the team · via Verve Therapeutics
Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.
Founders & leadership
Q32 Bio was founded in 2017 by Shelia Violette and Michael Holers.
SV
Shelia VioletteinFounder & Chief Scientific OfficerShelia Violette is Founder and Chief Scientific Officer of Q32 Bio, a biotechnology company developing therapies for autoimmune and inflammatory diseases. She has extensive experience in translational research and clinical drug development, particularly in inflammation, autoimmunity, and fibrosis.
MH
Michael HolersCo-founder
JM
LK
Lee KalowskiPresident & Chief Financial Officer
MM
Maria MarzilliinChief Business Officer
DA
David AppuglieseinSenior Vice President, Head of People
Investors · 6
Competitors · 5
by search overlap
StockTwits26 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Seeking Alpha21 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Q Bio, Inc.19 shared keywordsQ.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.
Qu Biologics19 shared keywordsQu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
Robinhood17 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with Q32 Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Q32 Bio do?
- Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.
- Who founded Q32 Bio?
- Q32 Bio was founded by Shelia Violette, Michael Holers in 2017.
- Who are Q32 Bio's investors?
- Q32 Bio's investors include Atlas Venture, OrbiMed, CU Healthcare Innovation Fund, OUP (Osage University Partners), Sanofi Ventures, Agent Capital.